Listed

Collegium Pharmaceutical, Inc

COLLNasdaqCIK 1267565HealthcareFiscal year ends Dec 31

Reports and events: 194 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Collegium Pharmaceutical, Inc, Reports and events
FiledFormWhat it isAccession number
2021-02-2516:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-001798
2021-01-0616:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-001485
2020-12-3016:53 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-20-140581
2020-11-0516:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-20-012856
2020-11-0516:03 ET10-QQuarterly reportPeriod 2020-09-300001558370-20-012836
2020-09-3008:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-110179
2020-09-2516:03 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-108894
2020-08-0516:08 ET10-QQuarterly reportPeriod 2020-06-300001558370-20-009387
2020-08-0516:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-20-009381
2020-07-0917:00 ET8-K5.02 Departure or appointment of officers or directors0001104659-20-082411
2020-05-2216:08 ET8-K5.07 Shareholder vote results0001104659-20-065356
2020-05-0716:27 ET10-QQuarterly reportPeriod 2020-03-310001558370-20-005738
2020-05-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-20-005680
2020-04-0916:01 ETDEF 14AProxy statementPeriod 2020-05-200001558370-20-003756
2020-02-2716:09 ET10-KAnnual reportPeriod 2019-12-310001558370-20-001625
2020-02-2716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-026155
2020-02-1317:10 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-020297
2020-02-1007:14 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-20-012830
2020-02-0616:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-011906
2020-01-2413:38 ETSC 13D/AOwnership report, active investor, amended0001193125-20-014002
2020-01-0716:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-001982
2019-11-0616:04 ET10-QQuarterly reportPeriod 2019-09-300001558370-19-010153
2019-11-0616:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-060492
2019-08-0716:03 ET10-QQuarterly reportPeriod 2019-06-300001558370-19-007458
2019-08-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-044526
2019-05-0816:03 ET10-QQuarterly reportPeriod 2019-03-310001558370-19-004446
2019-05-0816:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-027801
2019-04-3016:00 ET8-K5.07 Shareholder vote results0001104659-19-025274
2019-03-1516:01 ETDEF 14AProxy statementPeriod 2019-04-250001558370-19-002140
2019-02-2716:07 ET10-KAnnual reportPeriod 2018-12-310001558370-19-001187
2019-02-2716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-011087
2019-01-0708:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-19-000992
2018-11-0816:06 ET10-QQuarterly reportPeriod 2018-09-300001558370-18-009001
2018-11-0816:06 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001104659-18-066968
2018-08-0816:03 ET10-QQuarterly reportPeriod 2018-06-300001558370-18-006748
2018-08-0816:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-18-050488
2018-06-0416:01 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-18-037991
2018-05-2516:01 ET8-K5.07 Shareholder vote results0001104659-18-035995
2018-05-0916:07 ET10-QQuarterly reportPeriod 2018-03-310001558370-18-004474
2018-05-0916:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-18-031709
2018-04-1308:22 ETDEF 14AProxy statementPeriod 2018-05-240001558370-18-002953
2018-03-0717:13 ET10-KAnnual reportPeriod 2017-12-310001558370-18-001644
2018-03-0716:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-18-015546
2018-02-2612:09 ETSC 13D/AOwnership report, active investor, amended0001072613-18-000167
2018-02-2216:20 ET8-K8.01 Other events0001104659-18-011372
2018-01-1009:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-18-001560
2017-12-1417:04 ET8-K1.02 Termination of a material agreement0001104659-17-073384
2017-12-0416:36 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-071702
2017-12-0418:25 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-17-071469
2017-11-0816:03 ET10-QQuarterly reportPeriod 2017-09-300001558370-17-008530

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.